CrossChx Series C Brings $15 Million in Focused Growth Funding for Unique Startup
Key goals include widespread adoption of Unique Patient Identifier and increased distribution of Queue, patient registration product
CrossChx, the leader in healthcare identity, today announced it has raised a $15 million Series C financing round. Participants include Silicon Valley Bank, Khosla Ventures, Drive Capital, NCT Ventures and Moonshots Capital. The financing will be used to aggressively expand sales and distribution of Queue, the company’s flagship patient sign-in system used in hundreds of locations across the country.
“Queue finally provides a way for patients to safely log in to healthcare, giving providers the ability to deliver a more personable level of care and returning control of patient identities back to their rightful owners – the patients themselves,” said Sean Lane, Founder and CEO of CrossChx. “Queue signals a new era of patient registration, and this capital will provide the resources to fulfill demand and expand across the country.”
Since its founding in 2012, CrossChx has signed more than 350 health systems nationwide and created more than 50 million unique patient IDs for healthcare.
“Few companies in healthcare have achieved as much progress as quickly as CrossChx,” said Chris Olsen, Partner with Drive Capital. “We are continually inspired by the company’s passionate, revolutionary approach to creating patient-centered, data-rich solutions that improve processes for everyone, and we are pleased to play a role in its future.”
The Queue patient sign-in system is equipped with the company’s identity resolution software that accurately captures patient data, deduplicates records, catches errors in patient medical profiles, and verifies patients’ identities to prevent medical mistakes.
